Latest & greatest articles for endometriosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on endometriosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on endometriosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for endometriosis

41. Pregnancy outcomes in women with endometriosis: a national record linkage study (Abstract)

Pregnancy outcomes in women with endometriosis: a national record linkage study To determine pregnancy outcomes in women with endometriosis.A national population based cohort study using record linkage.Scotland.A cohort of 14 655 women followed up over a 30-year period (1981-2010).In a nationwide Scottish study, we compared pregnancy outcomes in 5375 women with surgically confirmed endometriosis with outcomes in 8710 women without endometriosis who were pregnant during the same time period (...) , socio-economic status and year of delivery, women with endometriosis when compared to women without endometriosis, had a significantly higher risk of early pregnancy complications with adjusted OR (95% CI) of 1.76 (1.44, 2.15) and 2.70 (1.09, 6.72) for miscarriage and ectopic pregnancy, respectively. A previous diagnosis of endometriosis was associated with a significantly increased risk of [adjusted OR (95% CI)] placenta praevia [2.24 (1.52, 3.31)], unexplained antepartum haemorrhage [1.67 (1.39

2016 EvidenceUpdates

42. The issues surrounding the pre‐operative TVS diagnosis of rectovaginal septum endometriosis Full Text available with Trip Pro

The issues surrounding the pre‐operative TVS diagnosis of rectovaginal septum endometriosis 28191201 2018 11 13 1836-6864 17 1 2014 Feb Australasian journal of ultrasound in medicine Australas J Ultrasound Med The issues surrounding the pre-operative TVS diagnosis of rectovaginal septum endometriosis. 2-3 10.1002/j.2205-0140.2014.tb00082.x Reid Shannon S University of Sydney. Condous George G Acute Gynaecology, Early Pregnancy and Advanced Endosurgery Unit Sydney Medical School University

2015 Australasian journal of ultrasound in medicine

43. Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? Full Text available with Trip Pro

Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? 28191234 2018 11 13 1836-6864 18 1 2015 Feb Australasian journal of ultrasound in medicine Australas J Ultrasound Med Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? 2 10.1002/j.2205-0140.2015.tb00021.x Reid Shannon S Acute Gynaecology Early Pregnancy and Advanced Endosurgery Unit Sydney Medical School

2015 Australasian journal of ultrasound in medicine

44. Capacity building in endometriosis ultrasound: are we there yet? Full Text available with Trip Pro

Capacity building in endometriosis ultrasound: are we there yet? 28191255 2019 01 12 1836-6864 18 4 2015 Nov Australasian journal of ultrasound in medicine Australas J Ultrasound Med Capacity building in endometriosis ultrasound: are we there yet? 129-131 10.1002/j.2205-0140.2015.tb00218.x Menakaya Uche A UA Staff SpecialistObstetrics and Gynecology Calvary Health CareBruce; Director, JUNIC Specialist Imaging and Women's CenterCharnwood Australian Capital TerritoryAustralia. eng Editorial 2015

2015 Australasian journal of ultrasound in medicine

45. Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis Full Text available with Trip Pro

Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis The aim of this study was to investigate the role of peripheral blood markers as additional diagnostic tools to transvaginal ultrasound (TVU) findings in the diagnosis of endometriosis.This study included 40 patients undergoing laparoscopy for suspected endometriosis from January to December 2012. Preoperative levels of serum CA125, CA19-9, CEA and mRNA expression levels for survivin and VEGF were obtained. Real-time PCR (...) was used to determine relative gene expression. A new diagnostic score was obtained by deploying the peripheral blood markers to the TVU findings. Statistical methods used were Chi-square, Fisher's, Student's t-test or the Mann - Whitney test.There was a statistically significant difference in serum CA125, survivin and VEGF levels in patients with endometriosis and those without endometriosis (p<0.001, p=0.025 and p=0.009, respectively). False negative TVU findings were noted in 3/13 patients (23.1

2015 Journal of medical biochemistry

46. Urinary biomarkers for the non-invasive diagnosis of endometriosis. (Abstract)

of the diagnostic accuracy of urinary biomarkers for the diagnosis of pelvic endometriosis compared to surgical diagnosis as a reference standard.2. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses.Urinary biomarkers were evaluated as replacement tests for surgical diagnosis and as triage tests to inform decisions to undertake surgery for endometriosis.The searches were not restricted to particular study design, language or publication dates (...) Urinary biomarkers for the non-invasive diagnosis of endometriosis. About 10% of reproductive-aged women suffer from endometriosis which is a costly chronic disease that causes pelvic pain and subfertility. Laparoscopy is the 'gold standard' diagnostic test for endometriosis, but it is expensive and carries surgical risks. Currently, there are no simple non-invasive or minimally-invasive tests available in clinical practice that accurately diagnoses endometriosis.1. To provide summary estimates

2015 Cochrane

47. Robotic single-site excision of ovarian endometrioma Full Text available with Trip Pro

Robotic single-site excision of ovarian endometrioma Conventional single-incision laparoscopic surgery has been successfully employed for treatment of ovarian endometriomas. However, this technique presents surgeons with formidable ergonomic challenges, that make its widespread adoption unlikely. Robotic assistance in single-incision laparoscopic surgery provides adequate instrument triangulation through a single fulcrum, while eliminating ergonomic challenges to the surgeon. The objective (...) of this video is to describe a novel technique of laparoscopic excision and ablation of ovarian endometriomas with single-site robotic assistance. Footage from a single surgical case is shown in our video. The da Vinci Si surgical system with da Vinci Single-Site platform was utilized. A flexible CO2 laser fiber was employed as the main energy tool. To describe a technique of single-incision laparoscopic excision and ablation of endometriomas with robotic assistance. Footage from a single surgical case

2015 Fertility research and practice

48. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial (Abstract)

Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial Seventy patients with stage III or IV endometriosis were randomly assigned to 2 groups after conservative surgery. Group O (n = 35) received 3 cycles of a 28-day gonadotropin-releasing hormone agonist (GnRH-a) treatment (goserelin, 3.6 mg) starting 3-5 days postoperatively. Group M (n = 35) received the same treatment starting on days 1-5 of menstruation. Groups were further (...) time in group M was much longer that than that in group O (P =.001), and the bleeding rate in group M was significantly higher than that in group O (P =.024, RR = 1.185). In patients with stage III or IV endometriosis, the efficacy of GnRH-a initiated 3-5 days postoperatively was equivalent to that of GnRH-a initiated on days 1-5 of menstruation. Female patients who initiated GnRH-a treatment 3-5 days postoperatively experienced less uterine bleeding during the first cycle of treatment.© 2015

2015 EvidenceUpdates Controlled trial quality: uncertain

49. Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe?

Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe? Hormone Therapy for the Menopause after Endometriosis Surgery - Friend or Foe? - Evidently Cochrane Search and hit Go By March 12, 2015 // In today’s guest blog, Dr Martin Hirsch explains about endometriosis and treatment choices for women who have the menopause induced because of it. It’s Menopause Week here at Evidently Cochrane and as a team including individual bloggers, Cochrane UK, Healthtalk and Menopause UK (...) with their NHS Change Day campaign to ‘Change the Change’, we are summarising the evidence surrounding the menopause to ensure women get the correct facts from reliable evidence. This blog aims to help women who have had the menopause induced through surgery for endometriosis make more informed health decisions at a time of significant change for their mind and body. Endometriosis – what is it and how do I know if I have it? Most women have heard of the menopause. They fear it, but for a select few women

2015 Evidently Cochrane

50. Interventions effective for endometriosis

Interventions effective for endometriosis Interventions effective for endometriosis | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Interventions effective for endometriosis Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2014 Cochrane PEARLS

51. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by If you’re a woman living with endometriosis, the chances are you’ll be coping with chronic pain, and you may be facing fertility problems too. Here we look at a new overview of Cochrane systematic reviews, which brings together the best available evidence on treatments for these two devastating aspects (...) of endometriosis. Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments

2014 Evidently Cochrane

52. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by If you’re a woman living with endometriosis, the chances are you’ll be coping with chronic pain, and you may be facing fertility problems too. Here we look at a new overview of Cochrane systematic reviews, which brings together the best available evidence on treatments for these two devastating aspects (...) of endometriosis. Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments

2014 Evidently Cochrane

53. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility - Evidently Cochrane Search and hit Go By March 20, 2014 // Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment (...) is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments, with or without surgery. For women with fertility problems associated with endometriosis, drug treatments, surgery and assisted reproductive technologies (ART) may all be considered. Overviews can really help if you are making decisions about treatments, as they bring together in one place the best evidence we have, summarising systematic reviews

2014 Evidently Cochrane

54. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by If you’re a woman living with endometriosis, the chances are you’ll be coping with chronic pain, and you may be facing fertility problems too. Here we look at a new overview of Cochrane systematic reviews, which brings together the best available evidence on treatments for these two devastating aspects (...) of endometriosis. Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments

2014 Evidently Cochrane

55. Endometriosis: an overview of Cochrane Reviews. Full Text available with Trip Pro

Endometriosis: an overview of Cochrane Reviews. This overview reports on interventions for pain relief and for subfertility in pre-menopausal women with clinically diagnosed endometriosis.The objective of this overview was to summarise the evidence from Cochrane systematic reviews on treatment options for women with pain or subfertility associated with endometriosis.Published Cochrane systematic reviews reporting pain or fertility outcomes in women with clinically diagnosed endometriosis were (...) cases the evidence was of low or very low quality. Anti-TNF-α drugs One review found no evidence of a difference in effectiveness between anti-TNF-α drugs and placebo. However, the evidence was of low quality. Reviews reporting fertility outcomes (8 reviews) Medical interventions Four reviews reported on medical interventions for improving fertility in women with endometriosis. One compared three months of GnRH agonists with a control in women undergoing assisted reproduction and found very low

2014 Cochrane

56. Treatment of pelvic pain associated with endometriosis: a committee opinion

HormonalContraceptives Combinedhormonalcontraceptiveshavebeenusedinbotha cyclicandacontinuousfashioninthetreatmentofsymptoms associated with endometriosis. Decidualization followed by atrophy of the endometrial tissue is the proposed mechanism of action (60). Whereas combined OCs containing the more androgenic progestogens (19-nortestosterone derivatives) traditionally have been used to treat endometriosis symp- toms,combinedOCscontainingthenewgenerationprogesto- gen, desogestrel, also have proven effective (61 (...) surgical treatment for endometriosis (63). Progestogens Progestogensmostcommonlyusedforthetreatmentofendo- metriosis include medroxyprogesterone acetate (MPA) and 19-nortestosteronederivatives(e.g.,levonorgestrel,norethin- drone acetate, and dienogest). As with OCs, their proposed mechanism of action involves decidualization and subse- quent atrophy of endometrial tissue. Another more recently proposedmechanisminvolvesprogestogen-inducedsuppres- sion of matrix metalloproteinases, a class of enzymes

2014 Society for Assisted Reproductive Technology

57. Endometriosis

Endometriosis Endometriosis - NICE CKS Share Endometriosis: Summary Endometriosis is the presence of tissue resembling endometrial glands and stroma outside the uterine cavity, which induces a chronic inflammatory reaction. It is often associated with dysmenorrhoea, pelvic pain, and subfertility. Most deposits occur in the pelvis, and this ectopic tissue is oestrogen-dependent and responds to the hormonal changes of the menstrual cycle. If the ovaries are affected, ovarian cysts (endometriomas (...) ) may develop. Subfertility may be due to distortion of pelvic anatomy due to adhesions or endometriomas, or disturbance of reproductive processes. Endometriosis is most commonly diagnosed in women between 30 and 40 years of age, and is uncommon in those younger than 20 years of age. The following signs and symptoms may indicate the presence of endometriosis. Symptoms typically start after several years of painless periods. Cyclical or chronic pelvic pain, usually before or during menstruation

2014 NICE Clinical Knowledge Summaries

58. Caesarean section and risk for endometriosis: a prospective cohort study of Swedish registries (Abstract)

caesarean deliveries. The risk of caesarean scar endometrioma was 0.1%.In addition to the recognised risk of scar endometrioma, we found an association between caesarean section and general pelvic endometriosis. Further studies are needed to confirm our findings.© 2013 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2013 RCOG. (...) Caesarean section and risk for endometriosis: a prospective cohort study of Swedish registries To investigate the association between caesarean section and later endometriosis.A prospective cohort study.The Swedish Patient Register (PAR) and the Swedish Medical Birth Registry (MBR).Women who were delivered in Sweden between 1986 and 2004.Women with the diagnosis of endometriosis, defined as codes 617 (International Classification of Diseases, ninth revision, ICD-9) or N80 (ICD-10), were

2013 EvidenceUpdates

59. Laparoscopic CO2 laser ablation for endometriosis

Laparoscopic CO2 laser ablation for endometriosis Laparoscopic CO2 laser ablation for endometriosis Laparoscopic CO2 laser ablation for endometriosis Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Laparoscopic CO2 laser ablation for endometriosis. Lansdale: HAYES, Inc.. Directory Publication. 2013 Authors' conclusions Laparoscopic carbon dioxide (CO2) laser (...) ablation (LCLA) is a nearly bloodless surgical procedure designed to vaporize abnormal tissues, including endometriotic lesions, with minimal damage to surrounding normal tissue. The most common purpose of LCLA in endometriosis is to restore fertility and/or relieve associated pelvic pain. The LCLA technique can be part of a diagnostic and therapeutic procedure. If employed to restore fertility, LCLA enables attempts at conception right after surgery without the typical several months of delay required

2013 Health Technology Assessment (HTA) Database.

60. Anti-TNF-α treatment for pelvic pain associated with endometriosis. (Abstract)

Anti-TNF-α treatment for pelvic pain associated with endometriosis. Endometriosis is a chronic, recurring condition that can develop during the reproductive years. It is characterised by the development of endometrial tissue outside the uterine cavity. It is the most common cause of pelvic pain in women. This endometrial tissue development is dependent on oestrogen produced primarily by the ovaries and, therefore, traditional management has focused on suppression of ovarian function. Mounting (...) evidence shows that altered immune function plays a crucial role in the genesis and development of endometriosis. In this review we considered modulation of the inflammation as an alternative approach.To determine the effectiveness and safety of anti-tumour necrosis factor-α (anti-TNF-α) treatment in the management of endometriosis in premenopausal women.For the first publication of this review, we searched for trials in the following databases (from their inception to August 2009): Cochrane Menstrual

2013 Cochrane